Compare Immunovant Inc. Common Stock (IMVT) vs Victoria's Secret & Co (VSXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Victoria's Secret & Co — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Victoria's Secret & Co trades at $87.1 (market cap $6.84B). The key difference: Immunovant Inc. Common Stock and Victoria's Secret & Co are close in size by market cap, and Victoria's Secret & Co is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Victoria's Secret & Co for 34 Days on average.
| IMVT | VSXY | |
|---|---|---|
Market Cap | $6.62B | $6.84B |
Volume | 1,131,364 | 774,930.85 |
Sector | Health | Consumer Cyclical |
52-Week High | $44.96 | $99.97 |
52-Week Low | $17.03 | $28.25 |
Typical Hold Time | 0 Days | 34 Days |
Enterprise Value | $5.72B | $9.22B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Victoria's Secret (VSXY) trades at $86.61, up 1.8% with bullish technical signals and strong earnings momentum after beating Q2 2026 estimates. The company shows improving fundamentals with revenue stabilizing at $6.2B and net income recovering to $165M. Analyst consensus remains positive with 60% buy ratings and a $86.80 price target, while recent news highlights the company's fashion show expansion and global growth initiatives.
The outlook appears favorable with projected 2026 revenue growth to $6.9B and net income of $378M, though elevated valuation metrics (P/E 19.15, P/B 6.91) and competitive retail pressures present risks. The stock offers exposure to a brand turnaround story with improving margins and institutional interest, but requires monitoring of consumer spending trends and execution on growth initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Victoria's Secret & Co
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →
